您的位置: 首页 > 2023年9月 第54卷 第9期 > 文字全文
2023年7月 第38卷 第7期11
目录

广东省某三甲医院门诊老年患者补充与替代医学使用现状及影响因素分析

Analysis of the current status and influencing factors of complementary and alternative medicine in a tertiary hospital

来源期刊: 广州医药 | 84-89 发布时间:2023-10-12 收稿时间:2025/11/13 18:31:12 阅读量:33
作者:
关键词:
老年人补充与替代医学影响因素
elderlycomplementary and alternative medicineinfluencing factors
DOI:
10.3969/j.issn.1000-8535.2023.09.015
收稿时间:
2023-05-08 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 了解门诊老年患者补充与替代医学(CAM)使用现状及影响因素。方法 采用便利抽样法,选取2020年11月—2021年2月广东省某三甲医院老年科门诊就诊的老年患者作为研究对象,调查方法采用一般资料调查表和CAM使用情况调查表进行横断面调查。应用二元Logistics回归分析探讨门诊老年患者使用CAM的影响因素。结果 参与调查的123例老年患者中,有75例(61.0%)老年患者使用CAM,使用CAM的项目主要为中草药、药膳等中国传统医学项目。支付方式是门诊老年患者是否使用CAM的影响因素,使用医保支付的患者较公费、自费患者更愿意使用CAM(OR=5.054,95%CI:1.452~17.590,P<0.05)。结论 CAM在门诊应用广泛,我们应充分发挥我国传统医学优势,为老年人疾病防治提供更多的思路。政府层面也可进一步提高医保覆盖范围,让更多的患者有经济能力可以接受安全、有效的治疗。
Objective To investigate the current status of complementary and alternative medicine(CAM)use and the influencing factors of elderly patients in outpatient clinic.Methods Using the convenience sampling method,the elderly patients treated in the geriatric outpatient department of a Class A tertiary Hospital in Guangdong from November 2020 to February 2021 were selected.General data and the CAM usage questionnaire were collected.Binary logistics regression analysis was used to explore the factors influencing CAM use in elderly patients.Results Seventy-five(61.0%)of 123 elderly patients used CAM.Chinese herbal medicine and medicinal diet were the most common CAM.Payment method was a factor affecting whether elderly outpatient patients use CAM.Insured patients were more willing to use CAM than self-funded patients(OR=5.054,95%CI:1.452-17.590,P<0.05).Conclusions CAM is widely used in outpatient clinics.We should make full use of our country’s traditional medicine,to provide different thoughts of diseases prevention and treatment in elderly patients.The government can also further enlarge the coverage of health insurance,so that more patients can afford safe and effective treatment.
1、 CARLSSON J M,VESTIN M,BJERS? K.Use of complementary and alternative medicine(CAM)among emergency department(ED)patients in Sweden[J].BMC Complement Med Ther,2020,20(1):327. CARLSSON J M,VESTIN M,BJERS? K.Use of complementary and alternative medicine(CAM)among emergency department(ED)patients in Sweden[J].BMC Complement Med Ther,2020,20(1):327.
2、 陈红,欧阳钢.补充和替代医学防治骨质疏松症的研究现状与展望[J].中国骨质疏松杂志,2014,20(11):1371-1374. 陈红,欧阳钢.补充和替代医学防治骨质疏松症的研究现状与展望[J].中国骨质疏松杂志,2014,20(11):1371-1374.
3、 张六一,李晶,张静平.补充和替代医学在老年期痴呆防治中的应用[J].中国老年学杂志,2015,35(13):3772-3774. 张六一,李晶,张静平.补充和替代医学在老年期痴呆防治中的应用[J].中国老年学杂志,2015,35(13):3772-3774.
4、 张莉,严芳,刘丽霞.补充与替代医学干预肺癌晚期疼痛患者的效果研究[J].护士进修杂志,2018,33(12):1070-1073. 张莉,严芳,刘丽霞.补充与替代医学干预肺癌晚期疼痛患者的效果研究[J].护士进修杂志,2018,33(12):1070-1073.
5、 王奕力,李雅竹,杨国彦,等.补充替代医学治疗腰椎间盘突出症的系统评价[J].中华中医药杂志,2017,32(8):3804-3808. 王奕力,李雅竹,杨国彦,等.补充替代医学治疗腰椎间盘突出症的系统评价[J].中华中医药杂志,2017,32(8):3804-3808.
6、 PATRICIA DE MORAES MELLO BOCCOLINI,CRISTIANO SIQUEIRA BOCCOLINI.巴西补充与替代医学(CAM)运用概况[J].亚太传统医药,2022,18(1):1-4. PATRICIA DE MORAES MELLO BOCCOLINI,CRISTIANO SIQUEIRA BOCCOLINI.巴西补充与替代医学(CAM)运用概况[J].亚太传统医药,2022,18(1):1-4.
7、 BARNES P M,POWELL-GRINER E,MCFANN K,et al.Complementary and alternative medicine use among adults:United States,2002[J].Adv Data,2004(343):1-19. BARNES P M,POWELL-GRINER E,MCFANN K,et al.Complementary and alternative medicine use among adults:United States,2002[J].Adv Data,2004(343):1-19.
8、 SILINA V,KALDA R.Challenges for clinical practice and research in family medicine in reducing the risk of chronic diseases.Notes on the EGPRN Spring Conference2017 in Riga[J].Eur J Gen Pract,2018,2 4(1):112-117. SILINA V,KALDA R.Challenges for clinical practice and research in family medicine in reducing the risk of chronic diseases.Notes on the EGPRN Spring Conference2017 in Riga[J].Eur J Gen Pract,2018,2 4(1):112-117.
9、 SCHRAM M T,FRIJTERS D,van de LISDONK E H,et al.Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly[J].J Clin Epidemiol,2008,61(11):1104-1112. SCHRAM M T,FRIJTERS D,van de LISDONK E H,et al.Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly[J].J Clin Epidemiol,2008,61(11):1104-1112.
10、 唐哲. 基于先秦哲学观的《黄帝内经》医学方法论研究[D].沈阳:辽宁中医药大学,2019. 唐哲. 基于先秦哲学观的《黄帝内经》医学方法论研究[D].沈阳:辽宁中医药大学,2019.
11、 孟晓媛,刘继东,段阿里,等.《黄帝内经》养生理论的内涵与当代价值[J].中华中医药杂志,2022,37(2):989-991. 孟晓媛,刘继东,段阿里,等.《黄帝内经》养生理论的内涵与当代价值[J].中华中医药杂志,2022,37(2):989-991.
12、 郭明义,田甜,付超,等.“健康中国”背景下中医“治未病”理念及现实意义探讨[J].中医药通报,2021,20(6):36-38. 郭明义,田甜,付超,等.“健康中国”背景下中医“治未病”理念及现实意义探讨[J].中医药通报,2021,20(6):36-38.
13、 袁成波,王檀,仕丽,等.轻型新型冠状病毒肺炎70例中医临床疗效回顾性分析[J].吉林中医药,2021,41(10):1329-1332. 袁成波,王檀,仕丽,等.轻型新型冠状病毒肺炎70例中医临床疗效回顾性分析[J].吉林中医药,2021,41(10):1329-1332.
14、 马春成,李叶枚,伍劲华.新型冠状病毒恢复期患者应用加减五叶芦根汤联合艾灸调适法临床疗效观察[J].亚太传统医药,2021,17(12):113-117. 马春成,李叶枚,伍劲华.新型冠状病毒恢复期患者应用加减五叶芦根汤联合艾灸调适法临床疗效观察[J].亚太传统医药,2021,17(12):113-117.
15、 冯利民,刘晓亚,张磊.宣肺败毒颗粒治疗新型冠状病毒肺炎(奥密克戎)的临床疗效观察[J].天津中医药,2022,39(5):545-550. 冯利民,刘晓亚,张磊.宣肺败毒颗粒治疗新型冠状病毒肺炎(奥密克戎)的临床疗效观察[J].天津中医药,2022,39(5):545-550.
16、 谢琪,李博,范为宇.NCCAM 卫生服务研究之五年计划目标[J].国际中医中药杂志,2006,28(6):324-326. 谢琪,李博,范为宇.NCCAM 卫生服务研究之五年计划目标[J].国际中医中药杂志,2006,28(6):324-326.
17、 CHEUNG C K,WYMAN J F,HALCON L L.Use of complementary and alternative therapies in community-dwelling older adults[J].J Altern Complement Med,2007,13(9):997-1006. CHEUNG C K,WYMAN J F,HALCON L L.Use of complementary and alternative therapies in community-dwelling older adults[J].J Altern Complement Med,2007,13(9):997-1006.
18、 National Center for Complementary and Alternative Medicine.NCCAM Third strategic plan:2011-2015:exploring the science of complementary and alternative medicine[R/OL].(2012-12)[2022-05-15].https://files.nccih.nih.gov/exploring-the-science-of-complementary-and-alternative-medicine-strategic-plan-2011-2015.pdf. National Center for Complementary and Alternative Medicine.NCCAM Third strategic plan:2011-2015:exploring the science of complementary and alternative medicine[R/OL].(2012-12)[2022-05-15].https://files.nccih.nih.gov/exploring-the-science-of-complementary-and-alternative-medicine-strategic-plan-2011-2015.pdf.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录